2012-09-17 07:10:01 - New Pharmaceuticals market report from Global Markets Direct: "Rheumatic Disorders - Pipeline Review, H2 2012"

Global Markets Direct's, 'Rheumatic Disorders - Pipeline Review, H2 2012', provides an overview of the Rheumatic Disorders therapeutic pipeline. This report provides information on the therapeutic development for Rheumatic Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rheumatic Disorders. 'Rheumatic Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463811_rheumatic_disorders_pipeline_review_h ..


Note*: Certain sections in the report may be removed or altered based

on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Rheumatic Disorders.
* A review of the Rheumatic Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Rheumatic Disorders pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Rheumatic Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Rheumatic Disorders pipeline depth and focus of Rheumatic Disorders therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Rheumatic Disorders Therapeutic Products under Development, Key Players in Rheumatic Disorders Therapeutics, Rheumatic Disorders Pipeline Overview, Rheumatic Disorders Pipeline, Rheumatic Disorders Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rheumatic Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Rheumatic Disorders
Rheumatic Disorders Therapeutics under Development by Companies
Rheumatic Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Rheumatic Disorders Therapeutics - Products under Development by Companies
Rheumatic Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Rheumatic Disorders Therapeutics Development
Rheumatic Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
PHY808 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prednisone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lupron Depot - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methylprednisolone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MRX-7EAT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rheumatic Disorders Therapeutics - Dormant Products
Rheumatic Disorders - Product Development Milestones
Featured News & Press Releases
Jan 12, 2011: Antares Pharma To Initiate Clinical Trial Of VIBEX MTX In First Quarter Of 2011
Mar 23, 2007: Medistem Laboratories Announces Tolerostem Platform As Second Pipeline Product for Potential U.S. Commercialization
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Rheumatic Disorders, H2 2012
Products under Development for Rheumatic Disorders - Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Number of Products under Investigation by Universities/Institutes, H2 2012
Comparative Analysis by Late Stage Development, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463811&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.